fluoxetine has been researched along with 3,4-methylenedioxyethamphetamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibb, JW; Hanson, GR; Johnson, M | 1 |
| Harvey, JA; McMaster, SE; Romano, AG | 1 |
| Cleary, L; Docherty, JR | 1 |
3 other study(ies) available for fluoxetine and 3,4-methylenedioxyethamphetamine
| Article | Year |
|---|---|
Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic system.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Analysis of Variance; Animals; Drug Interactions; Fluoxetine; Frontal Lobe; Hippocampus; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase; Pargyline; Rats; Rats, Inbred Strains; Serotonin; Tryptophan Hydroxylase | 1989 |
Methylenedioxyamphetamine: neurotoxic effects on serotonergic projections to brainstem nuclei in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Axonal Transport; Axons; Brain Stem; Designer Drugs; Fluoxetine; Immunohistochemistry; Male; Nerve Fibers; Neurotoxins; Prosencephalon; Rats; Rats, Sprague-Dawley; Serotonin | 1993 |
Actions of amphetamine derivatives and cathinone at the noradrenaline transporter.
Topics: 3,4-Methylenedioxyamphetamine; Adrenergic Uptake Inhibitors; Alkaloids; Amphetamines; Animals; Cerebral Cortex; Cocaine; Competitive Bidding; Fluoxetine; In Vitro Techniques; Male; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Wistar; Symporters | 2003 |